Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Monopar Therapeutics Inc
MNPR
Healthcare
Biotechnology
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for cancer patients. The Company is building a drug candidate pipeline through in-house development as well as the licensing and acquisition of therapeutics in late preclinical and in clinical development stages. The Company has several compounds in development, which include MNPR-101-Zr...
, MNPR-101-RIT, Camsirubicin and MNPR-202. MNPR-101-Zr is a clinical-stage urokinase plasminogen activator receptor (uPAR)-targeted radio diagnostic imaging agent. MNPR-101-RIT is a late preclinical stage radiotherapeutic for advanced cancers. Camsirubicin is an analog of doxorubicin which has been designed to reduce the cardiotoxic side effects generated by doxorubicin while retaining effective anti-cancer activity. MNPR-202 is an early-stage analog of camsirubicin designed to potentially treat doxorubicin- and camsirubicin-resistant cancers.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MNPR)
New Post
View:
Posts & Comments
Threaded Posts
(119)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on May 24, 2024 8:15pm
Monopar Announces CFO Succession
NEWS: $MNPR Monopar Announces CFO SuccessionWILMETTE, Ill., May 24, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on
...more
(119)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 16, 2024 8:45pm
Monopar Announces Filing of Patent Protecting MNPR-101 Radio
Just In: $MNPR Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization FindingsWILMETTE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a
...more
(119)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 27, 2024 9:30pm
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical
Breaking News: $MNPR Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical TrialWILMETTE, Ill., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage
...more
(119)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 22, 2024 1:15pm
What's Going On With Cancer-Focused Monopar Therapeutics Sto
JUST IN: $MNPR What's Going On With Cancer-Focused Monopar Therapeutics Stock Today? | BenzingaMonopar Therapeutics Inc@(NASDAQ:MNPR) shares jumped during the trading session on Thursday on a
...more
(119)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 22, 2024 12:30pm
Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 | Benz
NEWS: $MNPR Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 | BenzingaU.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping around 300 points on Thursday.The Dow
...more
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jul 14, 2023 11:19am
MNPR ..... Let's go Baby !
over $1.00 now
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jul 14, 2023 11:14am
MNPR ..... No Position ; )
Chers !
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jul 14, 2023 10:59am
MNPR ..... on watch
early a.m runner was in PB mode......now back thru resistance at $0.97.....rarely seen with these Chitco Co's on NASDAQ....usually waterfalls after H.O.D Cheers !
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Uranium Explorer to Commence Drill Program at Clearwater West Project in Saskatchewan
High-grade gold potential in the world’s best mining jurisdiction